Roberta Anson
Family · Warrensburg, MONPI 1154758175
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $940 and has fallen 84.9% since, to $142 in 2023.
Across 54 payments — averaging $27.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$306
- Eisai Inc.$165
- Genmab U.S., Inc.$136
- AstraZeneca$119
- Seagen Inc.$91
- Incyte Corporation$76
- plus $608 from 17 others
What the payments were for
- Food & beverage$1,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 9 | $306 |
| Eisai Inc. | 8 | $165 |
| Genmab U.S., Inc. | 2 | $136 |
| AstraZeneca | 2 | $119 |
| Seagen Inc. | 1 | $91 |
| Incyte Corporation | 4 | $76 |
| Merck | 1 | $74 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Blueprint Medicines Corporation | 3 | $46 |
| Exelixis Inc. | 2 | $45 |
| Mylan Institutional Inc. | 2 | $44 |
| Sanofi | 2 | $42 |
| Gilead | 2 | $40 |
| Clovis Oncology, Inc. | 2 | $36 |
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Blue Earth Diagnostics | 2 | $31 |
| Tersera Therapeutics LLC | 1 | $28 |
| Puma Biotechnology, Inc. | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $21 |
| G1 Therapeutics, Inc. | 1 | $21 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,503 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Other family in Warrensburg
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.